| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLSA | Exit | BCLS ACQUISITION CORP- CL A | $0 | – | -71,372 | -100.0% | -0.37% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -2,731,044 | -100.0% | -0.46% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -97,680 | -100.0% | -1.20% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -198,493 | -100.0% | -1.53% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCadr | $0 | – | -369,134 | -100.0% | -1.58% | – |
| Exit | DICE MOLECULES HOLDINGS ORD | $0 | – | -185,201 | -100.0% | -2.49% | – | |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -104,755 | -100.0% | -2.59% | – |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -143,204 | -100.0% | -3.22% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -375,989 | -100.0% | -3.34% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -43,876 | -100.0% | -3.42% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -139,445 | -100.0% | -3.50% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -502,275 | -100.0% | -3.73% | – |
| ARGX | Exit | ARGENX SE - ADRadr | $0 | – | -20,881 | -100.0% | -3.88% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -716,709 | -100.0% | -4.39% | – |
| NTRA | Exit | NATERA INC | $0 | – | -101,674 | -100.0% | -5.04% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -55,755 | -100.0% | -5.06% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -225,032 | -100.0% | -5.44% | – |
| BLU | Exit | BELLUS HEALTH INC | $0 | – | -1,280,757 | -100.0% | -5.47% | – |
| CNC | Exit | CENTENE CORP | $0 | – | -148,254 | -100.0% | -6.48% | – |
| IQV | Exit | IQVIA HOLDINGS INC | $0 | – | -44,314 | -100.0% | -6.64% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -94,448 | -100.0% | -6.79% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -26,844 | -100.0% | -7.16% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PLC | $0 | – | -137,610 | -100.0% | -7.87% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -177,741 | -100.0% | -8.34% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.